Thursday, May 21, 2015 1:34:09 AM
However, the point is there is no unreported inventory, there were reports of gains in genetically altered worms in birthing; but they have never kept enough worms alive to produce any meaningful inventory.
How do I know that? Because in order to constantly have more and more worms you must have more and more feed going into the costs. The feed for the worms is a major line item of costs and it exceeds their reported costs if you assume they are producing substantial inventory. It grossly exceeds their reported costs once you deduct from those reported costs all of the other identified line items (such as salaries and marketing and shares for professors, etc.).
Hence, there has not been any substantial production. I don't see any way that would be possible without having very substantial unreported costs. If they had very substantial unreported costs they would be sued and they would be fined very substantially; and, most likely the officers responsible would be barred from being participants in any Officer positions within any public companies.
Now, show me how it is possible to grow a substantial inventory without substantial spending and that might change my mind. But, you cannot produce silk from silkworms without feeding them and all of the other costs of caring for them. So, maybe now it looks like the synthetic approach to growing proteins that are the same as spider proteins has a huge potential advantage because of the lowered costs.... all depending on the conquest of spinning and the growth media remaining cheap, etc. Almost ironically, this also means that growing silkworm proteins in the same manner will ultimately replace the huge cottage industry that now exists for silk worm farming. That's typical in scientific advancement.
"You can fool all the people some of the time, and some of the people all the time, but you cannot fool all the people all the time."
Abraham Lincoln
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM